Global report - January 13, 2026
AbbVie and RemeGen in USD 5.6 billion oncology agreement
AbbVie and RemeGen have signed the first deal of the J.P Morgan Healthcare Conference 2026, with the companies agreeing to an exclusive oncology licensing agreement.
Global report - January 13, 2026
Eli Lilly and Nvidia commit USD 1 billion to AI co‑innovation lab
At the 2026 JPM Conference, Lilly and Nvidia announced an expanded AI partnership, including a USD 1 billion co‑innovation lab in the Bay Area to integrate advanced computing and biology for drug discovery.
Global report - December 9, 2025
Pfizer enters into agreement with YaoPharma
Pfizer has entered into an exclusive global collaboration and license agreement with YaoPharma, a subsidiary of Shanghai Fosun Pharmaceutical for the development, manufacturing and commercialization of YP05002, a small molecule glucagon-like peptide 1 (GLP-1) receptor agonist currently in Phase 1 development for chronic weight management.
Global report - November 24, 2025
AstraZeneca plans USD 2 billion manufacturing investment in Maryland
This is the fourth major US manufacturing investment announced this year.
Biotech Business - November 18, 2025
Sofinnova announces USD 750M fund that will invest in early stage biotechs
European life science VC firm Sofinnova Partners has announced the close of its latest flagship fund, Sofinnova Capital XI, at EUR 650 million (USD 750 million).
Global report - November 18, 2025
World AMR Awareness Week 2025
As one of WHO’s official health campaigns, the World AMR Awareness Week (WAAW) is mandated by the World Health Assembly and is commemorated annually from 18 to 24 November.
